Multiple Manufacturers

CYCLOPHOSPHAMIDE

Manufacturer:

Multiple Manufacturers

Cyclophosphamide HCPCS:

J8530

HCPCS Code Descriptor:

Cyclophosphamide; oral, 25 mg

Category:

J Code

Cyclophosphamide NDCs:

43975-0308-10, 00054-0383-25, 43975-0307-10, 00054-0382-25, 69097-0517-07, 10019-0984-01, 54879-0022-01, 62559-0930-01, 69097-0516-07, 10019-0982-01, 54879-0021-01

Primary Type:

Oncology

Generic/Specialty Status:

Multi-Source

Route of Administration:

Oral

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

43975-0308-10, 43975-0307-10, 54879-0022-01, 62559-0930-01, 54879-0021-01

About Cyclophosphamide:

CYCLOPHOSPHAMIDE is an Oncology drug manufactured by Cipla and administered via the Oral route of administration. The J Code: J8530 is aligned to the drug CYCLOPHOSPHAMIDE.

ACCESS PRICING AND MORE BY REGISTERING

J8530 Added Date:

January 1, 1995

J8530 Effective Date:

August 31, 1997

J8530 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Cyclophosphamide billing and coding information.
Our team did not identify a source for Cyclophosphamide patient assistance information. Please reach out to our team if you feel that this is a mistake.
CYCLOPHOSPHAMIDE prescribing information can be found at the link below:
Information regarding CYCLOPHOSPHAMIDE’s side effects can be found at MedlinePlus